Company

CEO

Satoshi S. Nishizuka, M.D., Ph.D.

Based on technologies and know-how developed at Iwate Medical University Institute for Biomedical Sciences, Quantdetect, Inc. was launched on April 1, 2021, with the intention of “implementing the research product”. Quantdetect provides assays that have been developed from our original technologies, leading to a safer and fulfilling future.

Company Name	Quantdetect, Inc.
Location	Headquarters TOKYO SANKEI Bldg 27F　1-7-2 Chiyoda, Tokyo 100-0004, Japan Tel: 03-3242-3146 Branches 1-7-35 Chuo-dori, Morioka-shi, Iwate 020-0021 Core Field Morioka 1-3rd floor Tel: 019-908-8105 Morioka Lab L1 Advanced Science and Technology Institute of Iwate, 2-4-26 Kitaiioka, Morioka, Iwate 020-0852, Japan Tel: 019-601-2340　Fax: 019-601-2341
Founder & CEO	Satoshi S. Nishizuka
Capital	24.936 million JPY
Business content	・ Supply highly sensitive diagnostic tools for quantifying ctDNA of cancer patients ・ Supply total system for quantifying extremely low level DNA ・ Supply DNA probes for quantifying extremely low level DNA ・ Management for academia-driven patents ・ Planning, production, commercialize, import, and export of international merchandise ・ Medical research consulting

Headquarters

Branches

Morioka Lab